Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous ętes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie 16. Juillet 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrčs et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 1966  Page précédente Page suivante
   
   Articles 1 - 20 / 39305  
   
Tumor microenvironment-oriented HNGCIscore identifies immunotherapy-sensitive subgroups in ICI retreatment of HER2-negative advanced gastric cancer.
Front Oncol
Song X, Wu Y, Zhu Y, He Y, Shi J, Ren K, Gao C.
PMID: 42459296 [PubMed]


Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan.
Dig Endosc
Hirai R, Yamamoto Y, Yasuda T, Yanagita T, Iwatsubo T, Tani Y, Yoshii S, Sakata Y, Iwagami H, Nozaka T, Uozumi T, Masui Y, Konishi J, Shiotsuki K, Kido K, Kano Y, Ohata K, Matsuura N, Dobashi A, Yoda Y, Kushida S, Yamamoto Y, Urabe Y, Yoshio T, Abe S, Kadota T, Takizawa K, Yano T, Ono H.
PMID: 42457578 [PubMed - indexed for MEDLINE]


Opium and opioid use and cancer risk: A systematic review and meta-analysis of epidemiological studies.
Cancer Treat Res Commun
Semnani K, Ghoreshi B, Mehrpour O, Sobhani S, Esmaeili M, Alirezaei A, Chaghamirzayi P, Mahdavi-Gorabi A, Rezaei N, Djalalinia S, Qorbani M.
PMID: 42456280 [PubMed - as supplied by publisher]


Effectiveness and safety of carbon ion radiotherapy for stage III non-small cell lung cancer: a single-center retrospective study.
Front Oncol
Zhao X, Wang B, Zhang Y, Li P, Liang X, Gong Q, Tian L, Qin T, Chen X, Li Z, Nie P, Zhang Y, Ye Y.
PMID: 42453889 [PubMed]


Smoking-attributable gastrointestinal cancer burden in Brazil, Russia, India, China and South Africa (BRICS) and Associated Economies: A Global Burden of Disease study analysis 1990-2023.
Tob Prev Cessat
Jiang W, Wang Y, Cheng R.
PMID: 42453357 [PubMed]


Pulses and Cancer Outcomes: A Scoping Review of Human Studies on Risk Reduction.
Nutrients
Mohd Nawi MN, Ibrahim N, Bee Yong T, Abd Rashed A, Rmt Balasubramaniam V.
PMID: 42451068 [PubMed - indexed for MEDLINE]


Cancer Diagnoses and Deaths in Hungary, 2011-2023: Nationwide Trends Before, During, and After the COVID-19 Pandemic.
Cancers (Basel)
Kiss Z, Szabó TG, Maráz A, Rokszin G, Horváth Z, Nagy P, Abonyi-Tóth Z, Kovács V, Surján O, Barcza Z, Kenessey I, Wéber A, Wittmann I, Molnár GA, Neuhauser N, Darida M, Köveskúti I, Tamás RB, Bogos K, Moldvay J, Gálffy G, Tamási L, Müller V, Krasznai ZT, Pápai-Székely Z, Baltás E, Gyulai RP, Boér K, Holló P, Kocsis J, Máté S, Nikolényi A, Novák Z, Rubovszky G, Dank M, Vokó Z.
PMID: 42449573 [PubMed]


Development and internal validation of a dynamic Prealbumin-Immune-Inflammation-NLR Prognostic Score (PINPS) for esophageal squamous cell carcinoma treated with immune checkpoint inhibitors: a retrospective cohort study.
BMC Cancer
Ding H, Hao S, He G, Zhao K, Ling Y.
PMID: 42449264 [PubMed - as supplied by publisher]


Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024).
Clin Oncol (R Coll Radiol)
Kalantri S, Kelley B, Freeman JQ, Akhiwu TO, Redman R.
PMID: 42447620 [PubMed - as supplied by publisher]


Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial.
Future Oncol
Liu T, Dan X, Li Q, Wang P, Chen Y, Tian J, Lin Z, Hu Y, Shi H, Ding Z.
PMID: 42446091 [PubMed - as supplied by publisher]


Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation.
ISME Commun
Yang L, Liu Y, Li J, Lv J, Zhang Q, Cong M, Shi H, Zhang H.
PMID: 42445733 [PubMed]


A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma.
Transl Cancer Res
Xiao WT, Wu SQ, Han YR, Song JH, He JY.
PMID: 42445408 [PubMed]


DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation.
Transl Cancer Res
Muad YA, Zhang L, Peng W, Ye L.
PMID: 42445401 [PubMed]


Accuracy of machine learning in detecting lymph node metastasis of esophageal cancer: a systematic review and meta-analysis.
Transl Cancer Res
Chen J, Weng J, Lin X.
PMID: 42445376 [PubMed]


Systemic Inflammation Response Index, Albumin, and Hemoglobin-Albumin-Lymphocyte-Platelet Score for Stage-Stratified Esophageal Cancer Discrimination: A Retrospective Case-Control Study.
Cancer Manag Res
Li Y, Cui Y, Liu M, Zhang J, Liu Y.
PMID: 42445223 [PubMed]


Prognostic value of pretreatment systemic immune-inflammation index for overall survival in esophageal squamous cell carcinoma in China: a systematic review and meta-analysis.
J Thorac Dis
He C, Chen K, Zhao Y, Ni L, He R, Zhang Y, Sun N, Li G, Lai Z.
PMID: 42444965 [PubMed]


CT-based deep learning predicts immunotherapy response in esophageal squamous cell cancer patients.
J Thorac Dis
Li T, Fan R, Liu Z, Xu S, Zhang X, Xu Z, Yi J, Wei Z, Wu W, Wu Y.
PMID: 42444933 [PubMed]


Response-adapted perioperative therapy for resectable esophageal cancer in the immunotherapy era: a narrative review.
J Thorac Dis
Yan Y, Lyu J, Chen Y, Leng X.
PMID: 42444886 [PubMed]


Development and validation of a clinically interpretable risk scoring system for predicting one-year all-cause mortality in esophageal cancer: a population-based study.
J Thorac Dis
Lin H, Ma M, Fei W, Lu Q, He B.
PMID: 42444861 [PubMed]


Prognostic role of hemoglobin, albumin, lymphocyte and platelet score in esophageal cancer: a systematic review and meta-analysis.
J Thorac Dis
Yang H, Luo Y, Hu Y.
PMID: 42444857 [PubMed]


   
   Articles 1 - 20 / 39305    Page 1 de 1966  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1